Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer

Sinja Taavitsainen; Alexander W. Wyatt; Matti Annala; Elisa Ledet; Kevin Beja; Patrick J. Miller; Marcus Moses; Matti Nykter; Kim N. Chi; Oliver Sartor

doi:10.1200/PO.19.00014

Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer

Sinja Taavitsainen
, Alexander W. Wyatt
, Matti Annala
, Elisa Ledet
, Kevin Beja
, Patrick J. Miller
, Marcus Moses
, Matti Nykter
, Kim N. Chi
, Oliver Sartor

Research output: Contribution to journal › Article › Scientific › peer-review

43 Citations (Scopus)

Original language	English
Journal	JCO Precision Oncology
Volume	3
DOIs	https://doi.org/10.1200/PO.19.00014
Publication status	Published - 2019
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publication forum classification

Publication forum level 1

Access to Document

10.1200/PO.19.00014

http://urn.fi/URN:NBN:fi:tuni-201909273572

Cite this

@article{812130d34e4b469a8764eca38ecc836a,

title = "Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer",

author = "Sinja Taavitsainen and Wyatt, \{Alexander W.\} and Matti Annala and Elisa Ledet and Kevin Beja and Miller, \{Patrick J.\} and Marcus Moses and Matti Nykter and Chi, \{Kim N.\} and Oliver Sartor",

year = "2019",

doi = "10.1200/PO.19.00014",

language = "English",

volume = "3",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer

AU - Taavitsainen, Sinja

AU - Wyatt, Alexander W.

AU - Annala, Matti

AU - Ledet, Elisa

AU - Beja, Kevin

AU - Miller, Patrick J.

AU - Moses, Marcus

AU - Nykter, Matti

AU - Chi, Kim N.

AU - Sartor, Oliver

PY - 2019

Y1 - 2019

U2 - 10.1200/PO.19.00014

DO - 10.1200/PO.19.00014

M3 - Article

SN - 2473-4284

VL - 3

JO - JCO Precision Oncology

JF - JCO Precision Oncology

ER -